Skip to main content
Log in

A new point mutation in a hypoxanthine phosphoribosyltransferase-deficient patient

  • Brief report
  • Published:
Pediatric Nephrology Aims and scope Submit manuscript

Abstract.

A 12-year-old boy was referred because of abdominal pain, gross hematuria, and passage of stones. Further evaluation showed growth delay, low average range of intellectual functioning, and a speech articulation disorder. No signs of self-mutilation or self-injurious behavior were present. He had hyperuricemia, hyperuricosuria, uric acid crystalluria, uric acid calculi, macrocytosis, megaloblastic bone marrow changes, and mild anemia. Hypoxanthine phosphoribosyltransferase (HPRT) enzyme activity was reduced to approximately 26% of normal. Polymerase chain reaction-single strand conformational polymorphism analysis of the HPRT gene in DNA isolated from the patient’s blood lymphocytes revealed a single nucleotide substitution at codon 200 in exon 8. The base change was a guanine to cytosine transversion, resulting in the conservative amino acid substitution of threonine in place of arginine. To our knowledge, this mutation has not previously been reported.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Additional information

Received June 24, 1996; received in revised form and accepted March 13, 1997

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hidalgo-Laos, R., Kedar, A., Williams, C. et al. A new point mutation in a hypoxanthine phosphoribosyltransferase-deficient patient. Pediatr Nephrol 11, 645–648 (1997). https://doi.org/10.1007/s004670050357

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s004670050357

Navigation